1Sackeim HA.Hie definition and meaning of treatment-resistant depression.J Clin Psychiatry,2001,62 Suppl 16:10-17.
2Gdndara Martin Jde L,AgUera-Ortiz L,Ferre-Navarrete F,et al.Tolerability and efficacy of combined antidepressant therapy.Actas Esp Psiquiatr,2002,30(2):75-84.
3Berlim MT,Turecki G.Definition,assessment,and staging of treatment-resistant refractory major depression:a review of current concepts and methods.Gin J Psychiatry,2007,52(1):46-54.
4Berlim MT,Fleck MP,Turecki G.Current trends in the assessment and somatic treatment of resistant/refractory major depression; an overview.Ann Med,2008,40(2):149-159.
5GEAA Group.Algorithm for the management of depression based on the antidepressant combinations.Acta Psychiatr Scand,2005,112 Suppl 428:36-40.
6Fang Y,Yuan C,Xu Y.Comparisons of the efficacy and tolerability of extended-release venlafaxine,mirtazapine,and paroxe-tine in treatment-resistant depression; a double-blind,randomized pilot study in a Chinese population.J Clin Psychopharma-col,2010,30(4):357-364.
8Blier P,Gobbi G,Turcotte JE,et al.Mirtazapine and paroxetine in major depression:a comparison of monotherapy versus their combination from treatment initiation.Eur Neuropsychopharma-col,2009,19(7):457-465.
